Volume : 08, Issue : 04, April – 2021

01.FORMULATION AND INVITRO EVALUATION OF ETHOSOMAL GELS CONTAINING SAXAGLIPTIN AS THE MODEL DRUG

Sd. Riyaz Hussain*, Dr. Pawan Kumar, Dr. Parwez Alam

 

Abstract :

The process Touitou et al (2000) was used with little change to prepare various ethosomal formulations with different levels of IPA (20% to 40%) and sonicity. It was simple and reproducible techniques. The prepared and discrete ethosomes have been developed. However, ethosomes are more uniform in size and small, necessary for skin penetration by the process of sonication. When the efficiency of the trap was compared, ethosomes containing 30 percent w/w IPA, which were generated by sonication, displayed the highest value with respect to all others, therefore, with 30 percent w/w IPA as the best formula for all other aspects, ethosomally provided by sonicity was completed. In all formulations, GF6 demonstrated full release of the drugs in 1440 min compared to other formulations. The in vitro release decreased with increased concentrations of polymer and copolymer. Centered on the research findings of the drug release process the drug discharge followed the non-fickian diffusion mechanism by formulations and followed the first order kinetics.
Key words: Ethosomes, Sonication, Transdermal, Entrapment, Stability.

Cite This Article:

Please cite this article in press Sd. Riyaz Hussain et al., Formulation and Invitro Evaluation of Ethosomal Gels Containing Saxagliptin As the Model Drug.., Indo Am. J. P. Sci, 2021; 08(04).

Number of Downloads : 10

References:

1. Jain N, Talegonkar S, Jain NK. Modern methods of accessing the blood stream: Evolving transdermal drug delivery techniques. The Study in Pharma. Sep – October 2004;41-60.
2. Jain NK. Advances in the distribution of controlled and innovative medications. 1ed, Publishing of New Delhi:stCBS; 2001; 428 – 451.
3. Jain S, Bhandra D, Jain S, and Jain NK. Transfersomes, a novel transdermal drug delivery carrier. 1st Version Controlled and Novel Drug Distribution. CBS New Delhi Publishers and Distributors 1997: 426 – 451.
4. Vyas SP, Khar RK. Managed principles and developments in drug distribution. Fresh Delhi’s Vallabhprakashan. The 2002 First Edition: 173 – 243.
5. Tuitou E, Godin B, and Weiss C. Improved transmission by Ethosomal carriers into and through the skin. Study on Substance Dev 2000; 50; 406 – 445.
6. Chien YW. Drug delivery systems for managed and modulated-release. In: Swarbrick J, Balyan JC, Pharmacy Science Encyclopaedia. New York: Dekker Marcel. From 1990;281-313.
7. Leon Shargel, Susanna Wu-Pong, Andrew BC Yu.Drug products with modified-release. In:Biopharmaceutics & Pharmacokinetics Applied, 5th ed. In 2004.
8. Meera C Singh, Ajinkya S Naik, Sawant SD. Method of delivery of transdermal medications with a big focus on transdermal patches. 2010 J Pharm Res; 3(10): 2537-2543.
9. Robinson JR, Lee VH. Controlled fundamentals and applications for drug distribution. Two-nd ed. New Delhi: Editors & Distributors of CBS; 2005; vol 29: 523-552.
10. KottaKranthi Kumar, Sasikanth K, Sabareesh M, Dorababu N. Diakerein cream formulation and assessment. Clinical Res of Asian J Pharm 2011; 4(2): 93-98.
11. Richard H Man, Jonathan Hadgraft. Transdermal drug delivery: problems of growth and effort for science. From Marcel Dekker. Vol 35: 1-16.
12. Kaplun-Frischoff Y and Touitou E. Skin permeation testosterone improvement through technique by eutectic drug development and association with skin lipids. 1997 J Pharm Sci; 86: 1394 – 9.
13. Bhavsar JD, Brahambhatt VG, Patel MR, Patel KR, Patel NM. Article of Review: Novel Semisolid Approaches. World Res 2011 Int J Pharm; 2(1): 1-22.
14. Khandare JN, Jiwandad BH and Uppal RR. Nimesulideniosomes for topical distribution planning and assessment. Int Drug 2001 April; 38(4): 197-202 respectively.
15. Facts on Medications and Reference. Facts and reference publication, edition of Missouri ® 1999: 25855.
16. Bhavana Vora, Khopade AJ and Jain NK. Transdermal device dependent on niosomes for distribution of contraceptives. Abstract of the 1996 IPC: AP59; 41.
17. Kaplun-Frischoff Y and Touitou E. Skin permeation testosterone improvement through technique by eutectic drug development and association with skin lipids. 1997 J Pharm Sci; 86: 1394 – 9.
18. Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A and Levi-Schaffer f. Mediated intracellular and ethosomal carrier transmission. 2001;22: 3053-3059 biomaterials.